This page is part of our public exclusion list — a transparency tool that shows which companies we screen out and why. It is not investment advice, and it is not an accusation. But it is subject to change as our understanding of the facts evolves.
Jasper Therapeutics Inc. is a biotechnology company whose core research and development activities involve animal testing. The company’s primary clinical-stage candidate, JSP191, is an antibody-based conditioning agent intended for use in stem cell transplants, and its preclinical development required testing on animals. This places the company within the broad pharmaceutical and biotech sector where animal models are routinely used to satisfy regulatory requirements for drug safety and efficacy before human trials.
While specific, publicly-available enforcement records detailing violations by Jasper Therapeutics are not cited in the gathered evidence, the company operates in an industry where animal testing is a standard, material component of the product development pathway. The evidence references general enforcement actions and public records targeting pharmaceutical companies and universities for animal welfare violations, indicating the regulatory and activist scrutiny endemic to this field. For a development-stage biotech firm like Jasper Therapeutics, animal testing is not incidental but central to its research pipeline and potential commercialization.
Research Sources
1 organization
Related Exclusions
Wondering what we do invest in?
The Naughty List
A digest of changes to our exclusion list — new additions, removals, and the evidence behind them. We review the list continuously as new evidence surfaces.
Companies appear on our exclusion list based on our investment judgment — not because they've done anything illegal. This is a difference of values and opinion, not an accusation of wrongdoing. Exclusion does not constitute a recommendation against investing in any company, and absence from the list does not constitute a recommendation to invest.
This information is provided for educational and transparency purposes only and should not be relied upon as investment advice. Data is drawn from independent watchdogs, NGOs, government registries, and Ethical Capital's ongoing research — see Research Sources for the full list.
Ethical Capital LLC is a state-registered investment adviser in Utah (CRD #316032). Registration does not imply a certain level of skill or training.